Jazz Pharmaceuticals (JAZZ) Capital Expenditures (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 361.47% |
| Dec 31, 2025 | 102.05% |
| Sep 30, 2025 | -196.67% |
| Jun 30, 2025 | 5,973.04% |
| Sep 30, 2024 | -297.36% |
| Jun 30, 2024 | 2.71% |
| Mar 31, 2024 | -31.66% |
| Dec 31, 2023 | 134.98% |
| Sep 30, 2023 | -25.09% |
| Jun 30, 2023 | 50.16% |
| Mar 31, 2023 | -59.25% |
| Dec 31, 2022 | 291.31% |
| Sep 30, 2022 | -139.93% |
| Jun 30, 2022 | -0.11% |
| Mar 31, 2022 | 23.33% |
| Dec 31, 2021 | 19.68% |
| Sep 30, 2021 | 16.02% |
| Jun 30, 2021 | 231.09% |
| Mar 31, 2021 | -47.31% |
| Dec 31, 2020 | 22.14% |
| Sep 30, 2020 | 25.24% |
| Jun 30, 2020 | -44.31% |
| Mar 31, 2020 | -32.32% |
| Dec 31, 2019 | -35.63% |
| Sep 30, 2019 | -20.60% |
| Jun 30, 2019 | 75.68% |
| Mar 31, 2019 | 54.36% |
| Dec 31, 2018 | 30.69% |
| Sep 30, 2018 | -4.65% |
| Jun 30, 2018 | -42.20% |
| Mar 31, 2018 | -19.48% |
| Dec 31, 2017 | 6.36% |
| Sep 30, 2017 | 2.40% |
| Jun 30, 2017 | 128.06% |
| Mar 31, 2017 | 179.87% |
| Dec 31, 2016 | -46.39% |
| Sep 30, 2016 | -33.01% |
| Jun 30, 2016 | 43.85% |
| Mar 31, 2016 | -26.58% |
| Dec 31, 2015 | -34.74% |
| Sep 30, 2015 | -60.38% |
| Jun 30, 2015 | -9.63% |
| Mar 31, 2015 | 6.36% |
| Dec 31, 2014 | 66.46% |
| Sep 30, 2014 | -26.89% |
| Jun 30, 2014 | 215.65% |
| Sep 30, 2013 | 45.94% |
| Jun 30, 2013 | 312.07% |
| Mar 31, 2013 | 16.28% |
| Dec 31, 2012 | -60.66% |
| Sep 30, 2012 | 13.13% |
| Jun 30, 2012 | 675.09% |
| Mar 31, 2012 | -62.30% |
| Dec 31, 2011 | 108.84% |
| Sep 30, 2011 | 281.05% |
| Jun 30, 2011 | 43.94% |
| Mar 31, 2011 | -41.59% |
| Dec 31, 2010 | -64.24% |